Company intelligence / Profile preview

Adesis

New Castle, Delaware, United Statesadesisinc.com ↗

Ownership: Private
Development stage: Commercial

Overview

Adesis specializes in organic and organometallic synthesis for the pharmaceutical, biopharmaceutical, biomaterials, and catalyst industries. It offers early-stage research support through to scale-up and specialty manufacturing as a CRO/CDMO partner.

Modalities: Small moleculeOrganic synthesisOrganometallic synthesis
Industry: Drug Discovery Services

Partnerships

Partners with biotech/pharma clients broadly

Beyond the preview

Go deeper on Adesis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adesis.

Explore the full profile